Keyphrases
Ethnically Diverse
100%
Cancer Experience
100%
BRCA mutation
100%
Diverse Groups
100%
Epithelial Ovarian Cancer
100%
Ashkenazi Jews
80%
Jewish
40%
Better Prognosis
40%
Non-hereditary
40%
Israeli
20%
Histology
20%
Age at Diagnosis
20%
Medical Center
20%
Ashkenazi
20%
Confidence Interval
20%
African American
20%
Breast Cancer Susceptibility Gene 1 (BRCA1)
20%
Uncommon mutation
20%
Non-carriers
20%
Mutation Type
20%
185delAG
20%
Progression-free Survival
20%
Median Survival
20%
Hispanic
20%
BRCA mutation Carriers
20%
BRCA1, BRCA2
20%
Ovarian Cancer Patients
20%
BRCA Carriers
20%
Median Overall Survival
20%
Cancer Population
20%
Stage at Diagnosis
20%
Cancer Etiology
20%
Heterogeneous Patients
20%
BRCA Status
20%
Medicine and Dentistry
BRCA Mutation
100%
Krukenberg Tumor
100%
BRCA1
40%
Malignant Neoplasm
20%
Overall Survival
20%
Progression Free Survival
20%
Diseases
20%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
Overall Survival
50%
Progression Free Survival
50%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
100%
Malignant Neoplasm
20%
Progression Free Survival
20%
Overall Survival
20%
Diseases
20%